Ditemukan 40503 dokumen yang sesuai dengan query :: Simpan CSV
In 2014, BPJS Kesehatan have claims ratios reached 104.73% while in BPJS Kesehatan Depok have claims ratios more than 100% per month in 2015. This condition means that the cost of claims incurred is greater than the premium income be accepted. Secondary Care Inpatient is one of the types of health services that receive the most claim costs for the utilization of health services. This research aims to examine the factors associated with the number of claims secondary care inpatient of participants National Health Insurance in BPJS Depok period September 2014- September 2015. This research is quantitative descriptive and applied cross-sectional design. Data were collect from secondary source, for example claims register data. The results showed that the age, length of stay, diagnosis of disease, severity level, care class, hospital type, the type of membership has a significant correlation with the number of the secondary care inpatient claims (p = 0,0005), whereas gender was not found to have a significant correlation with tthe number of the secondary care inpatient claims (p = 0,579). The variables most associated with the number of the secondary care inpatient claims are variable severity level 3. Keywords: Claims, Secondary Care Inpatient; National Health Insurance
Latar belakang: Penyakit menular, khususnya Tuberkulosis (TB), masih menjadi tantangan besar di Indonesia, dengan prevalensi yang tinggi dan dampak signifikan terhadap sistem kesehatan. Komorbiditas seperti Diabetes Mellitus (DM) dan koinfeksi HIV memperburuk pengobatan TB, memperpanjang durasi terapi, serta meningkatkan beban biaya. Penelitian ini bertujuan untuk menganalisis perbandingan biaya rawat inap pada pasien TB dengan komorbid DM dan koinfeksi HIV di fasilitas kesehatan Indonesia, khususnya yang terdaftar dalam program Jaminan Kesehatan Nasional (JKN). Tujuan: Mengetahui perbandingan biaya rawat inap pada layanan FKRTL peserta JKN penderita TB/DM dan TB/HIV di Indonesia selama satu tahun. Metode: Penelitian ini menggunakan pendekatan kuantitatif dengan studi cross-sectional menggunakan data sampel BPJS Kesehatan tahun 2023. Sampel penelitian ini adalah peserta dengan diagnosis primer TB yang memiliki diagnosis sekunder DM dan HIV pada pelayanan FKRTL. Hasil: Terdapat sebanyak 4.753 peserta RITL JKN tahun 2022. Dari total kunjungan, sebanyak 4.531 merupakan peserta komorbid TB/DM dan 232 peserta koinfeksi TB/HIV. Pada tahun 2022, BPJS Kesehatan membayarkan sebesar Rp28,8 miliar untuk peserta RITL komorbid TB/DM dan Rp3,1 miliar untuk peserta RITL koinfeksi TB/HIV. Kesimpulan: Faktor-faktor yang berhubungan dengan biaya komorbid TB/DM pada kunjungan RITL peserta JKN 2022 adalah umur, hak kelas rawat, segmen kepesertaan, dan rujukan FKTP. Sedangkan, faktor-faktor yang beruhubungan dengan biaya koinfeksi pada kunjungan RITL pada kunjungan peserta JKN 2022 adalah jenis kelamin, umur, hak kelas rawat, dan segmen kepesertaan.
Background: Infectious diseases, particularly Tuberculosis (TB), remain a major challenge in Indonesia, with high prevalence and significant impact on the healthcare system. Comorbidities such as Diabetes Mellitus (DM) and HIV coinfection worsen TB treatment, prolong therapy duration, and increase healthcare costs. This study aims to analyze the comparison of inpatient costs for TB patients with comorbid DM and HIV coinfection in Indonesian healthcare facilities, specifically those enrolled in the National Health Insurance (JKN) program. Objective: To determine the comparison of inpatient costs for JKN FKRTL services for TB/DM and TB/HIV patients in Indonesia over the course of one year. Method: This study employs a quantitative approach with a cross-sectional design using BPJS Health sample data from 2023. The research sample includes participants with a primary TB diagnosis and secondary diagnoses of DM and HIV in FKRTL services. Results: There were 4,753 JKN inpatient participants in 2022. Of these, 4,531 were TB/DM comorbid patients, and 232 were TB/HIV coinfected patients. In 2022, BPJS Health paid Rp28.8 billion for TB/DM comorbid patients and Rp3.1 billion for TB/HIV coinfected patients. Conclusion: Factors related to the cost of TB/DM comorbidity for JKN inpatient visits in 2022 include age, inpatient class entitlement, membership segment, and FKTP referral. Meanwhile, factors related to the cost of coinfection for JKN inpatient visits in 2022 include gender, age, inpatient class entitlement, and membership segment.